An assessment of the impact of dexmedetomidine on opioid use in a neonatal intensive care unit

References

• Chrysostomou C, Schulman SR, Castellanos MH, et al. A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr. 2014;164(2):276–282.
   PubMed Web of Science ®Google Scholar
• Borenstein-Levin L, Synnes A, Grunau RE, et al. Narcotics and sedative use in preterm neonates. J Pediatr. 2017;180:92–98.
   PubMed Web of Science ®Google Scholar
• Clark RH, Bloom BT, Spitzer AR, et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;117(6):1979–1987.
   PubMed Web of Science ®Google Scholar
• Anand K, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: primary outcomes from the NEOPAIN randomised trial. Lancet. 2004;363(9422):1673–1682.
   PubMed Web of Science ®Google Scholar
• Loepke AW. Developmental neurotoxicity of sedatives and anesthetics: a concern for neonatal and pediatric critical care medicine? Pediatr Crit Care Med. 2010;11(2):217–226.
   PubMed Web of Science ®Google Scholar
• McPherson C. Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment? J Pediatr Pharmacol Ther. 2012;17(4):351–364.
   PubMedGoogle Scholar
• Roze JC, Denizot S, Carbajal R, et al. Prolonged sedation and/or analgesia and 5-year neurodevelopment outcome in very preterm infants: results from the EPIPAGE cohort. Arch Pediatr Adolesc Med. 2008;162(8):728–733.
   PubMedGoogle Scholar
• Bhandari V, Bergqvist LL, Kronsberg SS, et al. Morphine administration and short-term pulmonary outcomes among ventilated preterm infants. Pediatrics. 2005;116(2):352–359.
   PubMed Web of Science ®Google Scholar
• Menon G, Boyle EM, Bergqvist LL, et al. Morphine analgesia and gastrointestinal morbidity in preterm infants: secondary results from the NEOPAIN trial. Arch Dis Child Fetal Neonatal Ed. 2008;93(5):F362–F367.
   PubMed Web of Science ®Google Scholar
• O’Mara K, Gal P, Wimmer J, et al. Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates. J Pediatr Pharmacol Therap. 2012;17(3):252–262.
   PubMedGoogle Scholar
• Mcpherson C, Grunau RE. Neonatal pain control and neurologic effects of anesthetics and sedatives in preterm infants. Clin Perinatol. 2014;41(1):209–227.
   PubMed Web of Science ®Google Scholar
• Oschman A, McCabe T, Kuhn RJ. Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients. Am J Health Syst Pharm. 2011;68(13):1233–1238.
   PubMed Web of Science ®Google Scholar
• Agthe AG, Kim GR, Mathias KB, et al. Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial. Pediatrics. 2009;123(5):e849–e856.
   PubMed Web of Science ®Google Scholar
• Hünseler C, Balling G, Röhlig C, et al. Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trial. Pediatr Crit Care Med. 2014;15(6):511–522.
   PubMed Web of Science ®Google Scholar
• van Hoorn CE, Hoeks SE, Essink H, et al. A systematic review and narrative synthesis on the histological and neurobehavioral long-term effects of dexmedetomidine. Paediatr Anaesth. 2019;29(2):125–136.
   PubMed Web of Science ®Google Scholar
• Laudenbach V, Mantz J, Lagercrantz H, et al. Effects of alpha [2]-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology. 2002;96(1):134–141.
   PubMed Web of Science ®Google Scholar
• Ma D, Hossain M, Rajakumaraswamy N, et al. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol. 2004;502(1–2):87–97.
   PubMed Web of Science ®Google Scholar
• Dahmani S, Paris A, Jannier V, et al. Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology. 2008;108(3):457–466.
   PubMed Web of Science ®Google Scholar
• Endesfelder S, Makki H, von Haefen C, et al. Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain. PLoS One. 2017;12(2):e0171498.
   PubMed Web of Science ®Google Scholar
• Lam F, Bhutta AT, Tobias JD, et al. Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease. Pediatr Cardiol. 2012;33(7):1069–1077.
   PubMed Web of Science ®Google Scholar
• Estkowski LM, Morris JL, Sinclair EA. Characterization of dexmedetomidine dosing and safety in neonates and infants. J Pediatr Pharmacol Therap. 2015;20:112–118.
   PubMedGoogle Scholar
• Gupta P, Whiteside W, Sabati A, et al. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease. Pediatr Crit Care Med. 2012;13:660–666.
   PubMed Web of Science ®Google Scholar
• Finnegan LP, Connaughton JF, Kron RE, et al. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1–2):141–158.
   PubMedGoogle Scholar
• Stevens B, Johnston C, Petryshen P, et al. Premature infant pain profile: development and initial validation. Clin J Pain. 1996;12(1):13–22.
   PubMed Web of Science ®Google Scholar
• O’Mara K, Weiss MD. Dexmedetomidine for sedation of neonates with HIE undergoing therapeutic hypothermia: a single-center experience. AJP Rep. 2018;8(3):e168–e173.
   PubMed Web of Science ®Google Scholar
• Sperotto F, Mondardini MC, Dell’Oste C, et al. Efficacy and safety of dexmedetomidine for prolonged sedation in the PICU: a prospective multicenter study. Pediatr Crit Care Med. 2020;21(7):625–636.
   PubMed Web of Science ®Google Scholar
• Dersch-Mills DA, Banasch HL, Yusuf K, et al. Dexmedetomidine use in a tertiary care NICU: a descriptive study. Ann Pharmacother. 2019;53(5):464–470.
   PubMed Web of Science ®Google Scholar
• Sellas MN, Kyllonen KC, Lepak MR, et al. Dexmedetomidine for the management of postoperative pain and sedation in newborns. J Pediatr Pharmacol Ther. 2019;24(3):227–233.
   PubMedGoogle Scholar
• Donnellan A, Sawyer J, Peach A, et al. Reducing exposure to opioid and benzodiazepine medications for pediatric cardiac intensive care patients: a quality improvement project. Pediatr Crit Care Med. 2019;20(4):340–349.
   PubMed Web of Science ®Google Scholar
• Curley MA, Wypij D, Watson RS, et al. Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial. JAMA. 2015;313(4):379–389.
   PubMed Web of Science ®Google Scholar